No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review
Toshi A. Furukawa(Kyoto University), Andrea Cipriani(Oxford Health NHS Foundation Trust), Stefan Leucht(TUM Klinikum), Philip J. Cowen(University of Oxford), Georgia Salanti(University of Bern)
Cited by 27
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k